Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Serology > Viral Diseases > Flashcards

Viral Diseases Flashcards

1
Q

HIV Size and Shape

A

Sphere-shaped enveloped retrovirus Gp120/gp41 protein complex anchored into the envelope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HIV Genetics

A

Two identical copies of ssRNA, Codes 3 enzymes

  • gag (p24, p40, p55): precursor for structural proteins
  • pol (p51 reverse transcriptase, p66): Rt and replictaion enzymes (integrase and protease)
  • env (gp41): glycoproteins in envelope for fuiosn and attachment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mechanism of HIV infection

A
  • Targets of HIV: T cells, monocytes, macrophages, NKC, dendritic cells of lymph nodes and organs such as microglial cells of brain
  • Adsorption of gp120 onto CD4 receptor; requires CXCR4 co-receptor for entry into T-cell, and CCR5 & CCR2 co-receptors for entry into macrophages
  • After entry, viral RNA transrcibed into DNA which integrates with host DNA
  • Active infection by viral replication and budding of virions
  • Alternatively, HIV remains hidden as provirus in latent infection
  • Evades immune system by cell-cell fusion, latent virions in vacuoles inside the cell etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Course of HIV Infection

A
  • Acute (Early): high biral replication, flu/mono-like symptoms about 3-6 wks after exposure
  • Latent phase: low viral levels as it cleared from circulation, with no apparent symptoms, lasts up to 10 years, CD4 cells gradually destroyed
  • Clinical AIDS stage: profound immunosuppression, high virla replication, absolute Th count of <200/µL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Laboratory Results of HIV

A

Initial viral replication results in increased levels of p24 antigen and viral RNA in host’s blood Decreased CD4 T cell population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HIV Laboratory Monitoring

A

Four types of tests used in diagnosis and monitoring of HIV infection:

  • CD4 Tcell enumeration
  • HIV antibody detection
  • HIV antigen detection
  • HIV nucleic acid detection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CD4 T cell enumeration

A
  • Reported as percentage, absolute cell count, or ratio of CD4:CD8 cells
  • If cell count falls below 200/µL, patient is classified as having AIDS (normal range 500-1300/µL)
  • Decrease in CD4 count results in an inverted ratio of less than 1:1 for CD4 to CD8 cells (normal is 2:1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HIV Antibody Detection

A
  • Standard screening method is ELISA
  • Standard confirmatory method is Western blot
  • Other tests include agglutination tests, dot-blot test, home test kits etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HIV Antigen Detection

A

p24 antigen testing by a solid-phase antigen capture enzyme immunoassay (EIA) P24 antigen becomes undetectable as host produces antibodies, hence can’t be used as screening test like ELISA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HIV Nucleic Acid Detection

A

Viral load testing by RT-PCR, branced chain DNA assay (bDNA), and nucleic acid sequence based amplification (NASBA) Standard RT-PCR detects 400-750,000 copies of HIV RNA per ml of plasma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HIV Screening with ELISA

A

Detects HIV antibody in serum to viral antigens coated onto a solid support

Types of ELISAs:

  • 1st generation: detects Abs to HIV-1 only
  • 2nd generation: detects Abs to both HIV-1 and HIV-2
  • 3rd generation: sandwich method, Abs in serum bind to recombinant HIV-1 and HIV-2 proteins coated onto wells, after washing enzyme-labelled HIV 1 and 2 antigens added which bind to already bound HIV-specific Abs
  • 4th generation: simultaneously detects HIV-1 and HIV-2 Abs plus p24 antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Problems with ELISA Screening in HIV

A

False-negative: Serum tested too early, immunosuppressive therapy, hypogammaglobulinemia, Improper handling of kits/reagents

False-positive: Repeated freeze-thawing of specimens, autoreactive antibodies, Multiple pregnancies, Severe hepatic disease, Malignancies, Passive immunoglobulin therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Positive HIV Confirmations

A

When any serum sample comes ELISA positive for HIV, repeat the ELISA for a second time for presence of HIV-antibodies in patient’s serum.

Second-time positive cases are confirmed by Western blot/HIVD

Immunoassay for separated HIV antigens (p24, p31, and gp41 or gp120) treated with patient serum. Western blot is considered positive when at least two out of three possible antibodies are detected in patient’s serum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vaccine Models

A
  • Recombinant Protein Vaccine: HIV gp120 protein vaccine, marketed as AIDSVAX is in Phase III trials
  • Safer to use Attenuated Viral Vaccine: Can trigger both humoral and cellular IR
  • Risk of reversion DNA Vaccine: Plasmid based DNA vaccine IR produced not protective enough
  • Prime Boost Strategy: Marketed as “DNA plus MVA” vaccine candidate contains genetically engineered plasmid plus modified vaccinia Ankarastrain virus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Current HIV Treatment

A
  • Highly Active Anti-retroviral Therapy (HAART)
  • Reverse transcriptase inhibitors
  • Protease inhibitors
  • Integrase inhibitors
  • Fusion inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Liver Function Tests (Hepatitis)

A
  • Bilirubin
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)

Serum levels are elevated in proportion to the amount of liver damage (enzymes are contained within the hepatocytes, inflammation causes their release; Bilirubin rises as liver damage continues)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acute Viral Hepatitis Tests

A
  • anti-HAV: an IgM antibody directed against Hepatitis A (HAV)
  • HBsAg (hepatitis B surface antigen),
  • anti-HBc: an IgM antibody directed against the hepatitis B core antigen
  • anti-HCV: antibody to Hepatitis C (HCV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hepatitis A

A
  • Route of Transmission: Fecal-oral
  • Chronic Infection: No (acute)
  • Prevention: pre/post exposure immunization
  • Member of the picornavirus family; various serotypes include rhinoviruses (common cold)
  • Non-enveloped – strand RNA packaged within capsids with icosahedral symmetry
  • Only hepatitis virus that can be propagated in tissue culture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hepatitis B

A
  • Route of Transmission: Percutaneous, Permucosal
  • Chronic Infection: Yes
  • Prevention: pre/post exposure immunization
  • Long incubation period
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hepatitis C

A
  • Route of Transmission: Percutaneous, Permucosal
  • Chronic Infection: Yes
  • Prevention: Blood Donor Screening, Behavior Modification
  • Longer incubation than A but shorter than B
  • Typically asymptomatic but high rate of progression to cirrhosis and HPC (Hepatic Cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hepatitis D

A
  • Route of Transmission: Percutaneous, Permucosal
  • Chronic Infection: yes, low risk with coinfection
  • Prevention: pre/post exposure immunization, behavior modification
  • Coinfection needed with Hepatitis B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hepatitis E

A
  • Route of Transmission: Fecal-oral
  • Chronic Infection: No (acute)
  • Prevention: Ensure safe drinking water
  • Average incubation: Average 40 days, Range 15-60 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Causes of Hepatitis A Infection

A

From close personal contact, child care, nursing homes, contaminated food, water HAV infects cells of the intestinal mucosa and, following replication, gains access to blood, then is delivered to Liver cells to replicate, the viral progeny accumulate in bile fluid and are delivered back to the GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ALT

A

Alanine aminotransferase, is a hepatocyte-specific activity that is released into circulation following hepatocellular necrosis

Used as marker for disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Hepatitis B Panel

A

This panel consists of four hepatitis B markers:

  • HBsAg
  • HBeAg
  • anti-HBe
  • anti-HBs
  • IgM antibody to the core antigen (anti-HBc IgM) may also be included
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Markers for Chronic Hepatitis Infections

A
  • Three markers are used to determine the stage of chronic infection: HBsAg, HBeAg, and anti-HBc total
  • HBsAg and anti-HBc total will almost always be present
  • Depending on the stage of the disease, HBeAg may or may not be present,
  • Chronically infected individuals with HBeAg typically have higher viral loads
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

HBV Vaccinations

A
  • 1st generation HBV vaccine: surface antigen purified from chronically-infected individuals and inactivated by a variety of techniques. Still used in many third world countries
  • Current vaccine: HBsAg subunit vaccine produced in yeast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Immunity Testing in HBV

A
  • Anti-HBs (antibody to the surface antigen) is the only marker for determining immunity to a HBV
  • Anti-HBs appears early and the titer may eventually decline.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Percutaneous Transmission of HCV

A
  • Injecting drug use
  • Clotting factors before viral inactivation
  • Transfusion, transplant from infected donor
  • Therapeutic (contaminated equipment, unsafe injection practices)
  • Occupational (needlestick)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Perinatal Transmission of HCV

A

Transmission only from women HCV-RNA positive at delivery

No association with:

  • Delivery method
  • Breastfeeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Mononucleosis Facts

A
  • Widely disseminated, ubiquitous
  • 95% of the world’s population is exposed to this virus
  • Adults: usually have protective antibodies to EBV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

EBV

A
  • EBV is member of the herpes family of virus, double-stranded DNA virus
  • EBV infects B-lymphs and epithelial cells, infection initiates in the throat, in an acute, benign,and self-limiting lymphoproliferative condition
33
Q

Viral Replication of EBV

A
  • Adsorption: the virus attaches to a cell- surface protein which functions as a viral receptor (usually a B lymphocyte)
  • Penetration and uncoating: the virus moves into the cell where the viral envelope then fuses with the vesicle membrane and releases the viral contents into the cell’s cytoplasm.
  • Establishment of latent infection
34
Q

EBV Antibody Detection

A
  1. VCA viral capsid Ag (IgM (early infection) IgG (lifelong antibody))
  2. EA early antigen (EA IgG: acute & Burkitt’s lymphoma)
  3. EBNA nuclear antigens (binds to the viral DNA and allows the EBV genome to be maintained in the B cell as a circular DNA episome) in convalescence
35
Q

Infection Phases in EBV

A
  • Primary infection: symptoms fever, malaise, sore throat, enlarged neck lymph nodes, splenomegaly.
  • Incubation: 10-50 days, lasts for one to four weeks
  • If lingers more than 6 months becomes chronic EBV infection, chronic fatigue syndrome, Hepatitis is a common complication
  • X-linked lymphoproliferative syndrome: a rare inherited disorder: develops a fatal primary infection.
36
Q

EBV Immune Response

A
  • Infection with EBV results in both humoral and cellular immunity to the virus.
  • Antibodies directed against viral structural proteins and EBNA is diagnostic for infection.
  • Cellular immune response is important for the control of EBV infection
  • Natural killer cells and CD4 & CD8 cytotoxic Tcells control the proliferation of EBV infected B cells during the primary infection
  • After recovery from an acute infection, HLA restricted cytotoxic T ells are important in controlling EBV
37
Q

EBV Effect on Cells

A
  • Atypical lymphocytes in mono are primary T cells, many of which are responding the EBV infected B cells.
  • Activation of the B-cells by EBV results in production of antibodies, causing elevated titers of heterophile antibodies, and sometimes cold agglutinins, cryoglobulins, rheumatoid factors, and antinuclear antibodies.
  • Chronic Active EBV infection: 3 features: severe illness of more that 6 months, histological evidence of organ disease (lungs, liver, bone marrow) and demonstration of EBV antigens or DNA in tissue.
38
Q

EBV Assoc. Diseases

A
  1. Nasopharyngeal Carcinoma
  2. Burkitt’s Lymphoma
  3. Hodgkin’s disease
  4. Lymphoproliferative disease
  5. Neoplasms of the thymus, parotid gland, and supraglottic larynx
  6. Can cause complications involving the cardiac, ocular, respiratory, hematologic, digestive, renal, and neurologic systems
  7. Neurologic syndromes: bells palsy, Guillian Barre syndrome, meningoencephalitis, Reye’s syndrome, myelitis, cranial nerve neuritis and psychotic disorders
39
Q

Nasopharyngeal Carcinoma and EBV

A

100% of these cases expresses the EBV proteins, have elevated titers of IgA antibody to EBV.

40
Q

Burkitt’s Lymphoma and EBV

A

A malignant lymphoma of the small B cells, particularly in Africa. Infection with malaria is thought to diminish the Tcell control of proliferating EBV infected B cells.

41
Q

Hodgkin’s Disease and EBV

A

Patients often have high titers of antibody to EBV structural proteins before the onset of the lymphoma.

42
Q

Lymphoproliferative Disease and EBV

A

(AIDs or congenital): these patients have impaired T cell immunity and are unable to control the proliferation of EBV infected B cells and have elevated levels of interleukin6, a B cell growth factor that may increase the proliferation of EBV B cells.

43
Q

Clinical Diagnosis of EBV Using Antibodies

A
  • Helpful in determining acute or past infection
  • VCA: viral capsid antigen IgM & IgG primary infection presence of IgM accompanied by rising IgG-VCA levels. Produced by infected B lymphs
  • EA: early antigen IgG not detected in about 20% of EBV infections, present in Burkitt’s lymphoma or nasopharyngeal carcinoma
44
Q

Heterophile Antibodies and EBV

A

Heterophil Ab of IM: IgM type of antibody, usually appears during the acute phase, the ag that stimulates its production is unknown.

Has these characteristics:

  1. Reacts SRBC, horse, ox red blood cells
  2. Absorbed with beef red blood cells
  3. Not absorbed with Forssman Ag (guinea pig kidney cells), Does not react with EBV-specific ag
45
Q

Paul-Bunnell test for IM Ab

A
  • Presumptive Testing, using Paul-Bunnell glycoproteins (antigens) on red cell membranes
  • Pt serum + SRBC = agglutination
  • If heterophile Ab present, it is not specific for IM Ab
46
Q

Davidsohn Differential test for IM Ab

A

Differential Testing highly specific for IM

Pt serum + guinea pig kidney/beef rbc=

  1. Antigen from guinea pig kidney cells which are rich in Forsmann ag will absorb Forssman AB and serum sickness Ab
  2. Beef erythrocytes are poor in Forsmann ag, but absorb the heteorphil ab of IM.
  3. Will only partially remove IM Abs.
  4. Absorption is detected by loss of ability to agglutinate SRBC
47
Q

Definition of a heterophile antibody

A

Stimulated by one antigen and reacts with an entirely unrelated surface antigen present on cells

48
Q

Summary of mononucleosis test by latex agglutination

A

Tests for the IgM heterophile antibody by using agglutination of sheep red blood cells, Forssman antibodies may be absorbed out with a guinea pig kidney antigen

Positive tests are associated with hepatitis, rubella, leukemia, rheumatoid arthritis, Burkitt’s lymphoma and other pathological conditions

49
Q

Mono spot test interpretation

A

1+ small clumping with opaque fluid in background

2+ moderate clumping with fluid slightly opaque and background

3+ large clumping with clear background

50
Q

Early EBV infection

A

When primary infection is delayed until adulthood, there’s a 50% chance that it will occur with classic clinical manifestations of mononucleosis

51
Q

Early EBV infection antigens

A

EBV induced nuclear antigen (EBNA), EBV induced early antigen (EA), viral capsid antigen (VCA), and EBV induced membrane antigen (MA) IgM antibodies to VCA are detectable in the early course of disease

52
Q

Rubella

A
  • Single-stranded RNA virus, two viral envelopes
  • Causes German or 3-day measles
  • Symptoms: rash, fever, malaise, upper respiratory infectious route
  • Age: 5-14yr olds
  • Congenital rubella: maternal infection can lead to congenital defects - CHF, hepatitis, low birth weight, diabetes
53
Q

Rubella Laboratory Diagnosis and Vaccination

A
  • Latex agglutination and EIA
  • Titer of 1:8 is considered immune, a 4-fold increase in titer with symptoms indicates recent rubella infection
  • Vaccination: in 1962-1965, worldwide epidemic lead to immune program-new strains developed
54
Q

Cytomegalovirus (CMV)

A
  • Large, enveloped DNA virus, ubiquitous
  • Spreads from cell to cell
  • Transmitted through prolonged close contact with infectious body fluids (ie. Sexual contact to transfusion/transplantation)
  • Acquired CMV is usually asymptomatic, occasionally it is self- limited, heterophile negative, mono-like syndrome with sore throat, fever, malaise. In latent disease, virus can reactivated with appropriate stimuli
55
Q

Patients at risk for CMV Infection

A

Immunocompromised, HIV pos, or transplant patients

56
Q

HSV1 and HSV2

A
  • Herpes Simplex Virus 1: causes cold sores, mainly in the mucosal membranes of the mouth
  • Herpes Simplex Virus 2: watery blisters on mucous membranes of genitals
  • Both become latent and have periodic reactivation
57
Q

Laboratory Testing of HSV1 and HSV2

A
  • Viral culture from swabs of lesions, using direct immunofluorescence of the Herpes Ag.
  • Serological tests require a significant titer rise to be useful - PCR for HSV nucleic acid
58
Q

Chicken Pox/Shingles Lab Testing

A
  • Direct immunofluorescence of the Herpes Ag from lesion scrapings
  • PCR for VZV DNA
  • FAMA (Fluorescent Ab to Membrane Ag)
59
Q

Herpes Virus Facts

A
  • DNA virus, HSV- 2 identified as genital virus
  • Transmitted perinatally if mom is in active state at time of delivery, can be fatal to infant
60
Q

Appearance of Serological Markers in Hep. B

A
61
Q

Congenital Rubella

A

Can cause deafness, eye defects, cardiac abnormalities, mental retardation, and motor disabilities

62
Q

Laboratory Testing of Rubella

A
  • Hemagglutination inhibition
  • Passive hemagglutination
  • Complement fixation
  • Latex agglutination
  • Immunoassays
63
Q

HBsAg

A

First to appear (2-10 wks), peaks in acute phases then declines as Pt developns Ab

Indicates active infection

64
Q

HBeAg

A

Appears after HBsAg and disappears slightly before it in recovering patients, appears during periods of high replication

65
Q

IgM HBc

A

Current/recent infection (1-2 wks post HBsAg), persists in high titers for 4-6 mos.

66
Q

IgG HBc

A

Appears before IgM HBc is gone and persists for life

67
Q

anti-HBe

A

Shortly after HBe disappears, indicates recovery

68
Q

CMV Symptoms

A

Fever, myalgia, and fatigue

69
Q

CMV Laboratory Testing

A

Viral Culture, Viral Ag assays, Molecular assays and Serology

70
Q

Rubeola Symptoms

A

Causes Measles

  • Characteristic grey/white lesions in mouth surrounded by highly inflamed tissue
  • Fever
  • Cough
  • Runny nose
  • Conjunctivitis
71
Q

Ig Testing in Rubeola

A

IgM is more frequently looked for due to its indication of early infection and low risk of false positives with ELISA

72
Q

Laboratory Testing of Rubeola

A
  • ELISA
  • Hemagglutination inhibition
  • Microneutralization
  • Complement fixation
  • Indirect fluorescent Ab tests
  • PCR
73
Q

Symptoms of Mumps

A

Inflammation of Parotid Glands

74
Q

Rubeola Virus

A
  • Single-stranded RNA virus
  • Enveloped
  • Genus Morbillivirus
75
Q

Mumps Virus

A
  • Enveloped
  • Single-stranded RNA virus
  • Rubulavirus genus
76
Q

DNA Viruses

A
  • EBV
  • CMV
  • Herpes
77
Q

RNA Non-enveloped Viruses

A

Hepatitis A and E

78
Q

RNA Enveloped Viruses

A
  • HIV
  • Rubella
  • Rubeola
  • Mumps
  • Hepatitis B, C, D

Serology (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions